Cargando…
Cellular senescence induced by S100A9 in mesenchymal stromal cells through NLRP3 inflammasome activation
Bone marrow stromal cells from patients with myelodysplastic syndrome (MDS) display a senescence phenotype, but the underlying mechanism has not been elucidated. Pro-inflammatory signaling within the malignant clone and the bone marrow microenvironment has been identified as a key pathogenetic drive...
Autores principales: | Shi, Lei, Zhao, Youshan, Fei, Chengming, Guo, Juan, Jia, Yan, Wu, Dong, Wu, Lingyun, Chang, Chunkang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874461/ https://www.ncbi.nlm.nih.gov/pubmed/31727865 http://dx.doi.org/10.18632/aging.102409 |
Ejemplares similares
-
Iron overload promotes mitochondrial fragmentation in mesenchymal stromal cells from myelodysplastic syndrome patients through activation of the AMPK/MFF/Drp1 pathway
por: Zheng, Qingqing, et al.
Publicado: (2018) -
Downregulation of MMP1 in MDS-derived mesenchymal stromal cells reduces the capacity to restrict MDS cell proliferation
por: Zhao, Sida, et al.
Publicado: (2017) -
Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells
por: Guo, Juan, et al.
Publicado: (2018) -
S100a9 deficiency accelerates MDS-associated tumor escape via PD-1/PD-L1 overexpression: S100a9 deficiency accelerates tumor escape
por: Wang, Roujia, et al.
Publicado: (2023) -
Lenalidomide restores the osteogenic differentiation of bone marrow mesenchymal stem cells from multiple myeloma patients via deactivating Notch signaling pathway
por: Guo, Juan, et al.
Publicado: (2017)